The news: Oura’s US IPO filing late last week revealed a profitable company growing product and subscription revenues. The company is expected to seek a valuation upward of $16 billion, according to media reports.

Per Oura’s S-1:

• Revenues rose 74% to $1.2 billion in the first nine months of its fiscal year. It reported a net loss attributable to stockholders of $924.3 million, which experts say is a preferred stock buyback rather than an operational failure.
• Net income surged to $60.8 million in the same nine-month period from $1.57 million a year earlier. The company has been profitable since 2024.
• 3.1 million smart rings were sold in the first nine months of its fiscal year, up 72% from 1.8 million YoY.
• Paid membership doubled YoY to about 5 million customers. Its paid member retention rate reached 87% in fiscal year 2025, increasing from 85% the year prior and 81% in 2023.
• About 80% of revenues come from hardware sales, and 20% from customer memberships.

Why it matters: Despite Oura’s growth, the company reported that it accounted for just 2% of global wearable shipments in the past year. This is likely a reflection of the more established smartwatch and fitness tracker categories and Oura’s early stage of international expansion. At the same time, Oura does control the global smart ring market with 79% share, per Smart Analytics Global.

Leading the smart ring market may take Oura only so far. The company aims to use member data to expand into clinical and preventive health through integrations and increased distribution partnerships with insurers, providers, employers, sports teams, government entities, and technology companies. Oura estimates its serviceable addressable market at more than $90 billion across not just wearable sales, but also health coaching, digital care management, digital therapeutics, and connected biosensors. Employer- and healthcare-sponsored access could subsidize adoption and create a more efficient customer-acquisition channel.

Implications for consumer health brands: Oura’s filing comes amid strong consumer demand for wearables that track health beyond basic steps and calories. The Oura Ring tracks sleep, heart health, temperature, stress, and ovulation, providing personalized coaching or guidance based on user health and activity data.

Still, current consumer demand and ring sales alone may not be enough for Oura to thrive on the public market. Oura admitted that it expects its recent impressive growth to slow and wearable competition to intensify, while consumer interest could fade if shoppers pull back on pricey devices. (The Oura Ring costs $349 to $499, plus a monthly subscription.)

That’s why Oura is positioning itself as an AI-powered health intelligence platform rather than merely a hardware maker. For that bet to pay off under public-market scrutiny, medical and wellness partners will need to trust the accuracy of its device data and the reliability of its health guidance.

This content is part of EMARKETER’s subscription Briefings, where we pair daily updates with data and analysis from forecasts and research reports. Our Briefings prepare you to start your day informed, to provide critical insights in an important meeting, and to understand the context of what’s happening in your industry. Not a subscriber? Click here to get a demo of our full platform and coverage.